Shares of drugmaker Mylan (MYL) are soaring Monday and were up about 8.6% shortly after 12 p.m. EDT. That gives shares of the embattled company a welcome respite after they crashed to a new three-year low on Friday.
The stock’s Monday morning rebound has to do with Friday’s news that Mylan reached a settlement with the government over how it charges Medicaid for its signature product, the EpiPen.
